High Dose D-Serine as Adjuvant Treatment for Recent Onset Schizophrenia : A Randomized, Double-Blind, Placebo-Controlled Study
Latest Information Update: 18 Sep 2021
At a glance
- Drugs D-serine (Primary)
- Indications Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- Acronyms SATROS
- 28 Oct 2011 New trial record
- 25 Oct 2011 Biomarkers information updated